KR20230126707A - Cd34 유전자 변형을 위한 조성물 및 방법 - Google Patents

Info

Publication number

KR20230126707A

KR20230126707A KR1020237020742A KR20237020742A KR20230126707A KR 20230126707 A KR20230126707 A KR 20230126707A KR 1020237020742 A KR1020237020742 A KR 1020237020742A KR 20237020742 A KR20237020742 A KR 20237020742A KR 20230126707 A KR20230126707 A KR 20230126707A

Authority

KR

South Korea

Prior art keywords

cell

cells

grna

genetically engineered

hematopoietic

Prior art date

2020-12-31

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 109
• 101150118155 Cd34 gene Proteins 0.000 title abstract description 31
• 239000000203 mixture Substances 0.000 title description 24
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims abstract description 607
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims abstract description 607
• 108020005004 Guide RNA Proteins 0.000 claims abstract description 392
• 230000008685 targeting Effects 0.000 claims abstract description 119
• 238000012217 deletion Methods 0.000 claims abstract description 17
• 230000037430 deletion Effects 0.000 claims abstract description 17
• 238000003780 insertion Methods 0.000 claims abstract description 14
• 230000037431 insertion Effects 0.000 claims abstract description 14
• 208000002250 Hematologic Neoplasms Diseases 0.000 claims abstract description 11
• 230000009033 hematopoietic malignancy Effects 0.000 claims abstract description 10
• 210000004027 cell Anatomy 0.000 claims description 695
• 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 386
• 125000003729 nucleotide group Chemical group 0.000 claims description 191
• 101710163270 Nuclease Proteins 0.000 claims description 130
• 108091033409 CRISPR Proteins 0.000 claims description 90
• 230000027455 binding Effects 0.000 claims description 81
• 239000000427 antigen Substances 0.000 claims description 80
• 108091007433 antigens Proteins 0.000 claims description 80
• 102000036639 antigens Human genes 0.000 claims description 80
• 108090000623 proteins and genes Proteins 0.000 claims description 79
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 74
• 206010028980 Neoplasm Diseases 0.000 claims description 62
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 60
• 238000004520 electroporation Methods 0.000 claims description 59
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 54
• 210000000130 stem cell Anatomy 0.000 claims description 52
• 150000007523 nucleic acids Chemical class 0.000 claims description 47
• 101710160107 Outer membrane protein A Proteins 0.000 claims description 44
• 238000012986 modification Methods 0.000 claims description 44
• 241000282414 Homo sapiens Species 0.000 claims description 43
• 201000011510 cancer Diseases 0.000 claims description 42
• 239000012642 immune effector Substances 0.000 claims description 39
• 229940121354 immunomodulator Drugs 0.000 claims description 39
• 229940049595 antibody-drug conjugate Drugs 0.000 claims description 38
• 201000010099 disease Diseases 0.000 claims description 38
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 37
• 102000039446 nucleic acids Human genes 0.000 claims description 36
• 108020004707 nucleic acids Proteins 0.000 claims description 36
• 239000000611 antibody drug conjugate Substances 0.000 claims description 35
• 230000002829 reductive effect Effects 0.000 claims description 31
• 210000004698 lymphocyte Anatomy 0.000 claims description 30
• 102000004169 proteins and genes Human genes 0.000 claims description 30
• 230000004048 modification Effects 0.000 claims description 27
• 239000003795 chemical substances by application Substances 0.000 claims description 26
• 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims description 24
• 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims description 24
• 230000003211 malignant effect Effects 0.000 claims description 24
• 238000010453 CRISPR/Cas method Methods 0.000 claims description 22
• 230000036210 malignancy Effects 0.000 claims description 22
• 239000012634 fragment Substances 0.000 claims description 21
• 102100030024 Endothelial protein C receptor Human genes 0.000 claims description 20
• 101001012038 Homo sapiens Endothelial protein C receptor Proteins 0.000 claims description 20
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 19
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 19
• 101000994378 Homo sapiens Integrin alpha-3 Proteins 0.000 claims description 19
• 102100032819 Integrin alpha-3 Human genes 0.000 claims description 19
• 230000000295 complement effect Effects 0.000 claims description 17
• 230000035772 mutation Effects 0.000 claims description 16
• 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims description 13
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 13
• 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims description 13
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 13
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims description 12
• 102100022338 Integrin alpha-M Human genes 0.000 claims description 12
• 239000003550 marker Substances 0.000 claims description 12
• 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 claims description 11
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 11
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims description 11
• 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims description 11
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 11
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 11
• 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 claims description 10
• 102100035716 Glycophorin-A Human genes 0.000 claims description 10
• 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 claims description 10
• 101001074244 Homo sapiens Glycophorin-A Proteins 0.000 claims description 10
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims description 10
• 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 claims description 10
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims description 10
• 102100026144 Transferrin receptor protein 1 Human genes 0.000 claims description 10
• 230000006780 non-homologous end joining Effects 0.000 claims description 10
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims description 10
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 9
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 9
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 9
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims description 9
• 230000034431 double-strand break repair via homologous recombination Effects 0.000 claims description 9
• 208000023275 Autoimmune disease Diseases 0.000 claims description 8
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 8
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 8
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 8
• 238000004519 manufacturing process Methods 0.000 claims description 8
• 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims description 7
• 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims description 7
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 7
• 102100027208 T-cell antigen CD7 Human genes 0.000 claims description 7
• 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims description 7
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 7
• 210000000777 hematopoietic system Anatomy 0.000 claims description 7
• 230000007774 longterm Effects 0.000 claims description 7
• 108020004999 messenger RNA Proteins 0.000 claims description 6
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 5
• 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 claims description 5
• 102100025423 Bone morphogenetic protein receptor type-1A Human genes 0.000 claims description 5
• 102100027052 Bone morphogenetic protein receptor type-1B Human genes 0.000 claims description 5
• 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims description 5
• 102100035350 CUB domain-containing protein 1 Human genes 0.000 claims description 5
• 102100036364 Cadherin-2 Human genes 0.000 claims description 5
• 102100028461 Frizzled-9 Human genes 0.000 claims description 5
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 5
• 101000984546 Homo sapiens Bone morphogenetic protein receptor type-1B Proteins 0.000 claims description 5
• 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 claims description 5
• 102100032239 Melanotransferrin Human genes 0.000 claims description 5
• 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims description 5
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims description 5
• BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims description 4
• 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims description 4
• 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims description 4
• 101710188619 C-type lectin domain family 12 member A Proteins 0.000 claims description 4
• 101000934376 Homo sapiens T-cell differentiation antigen CD6 Proteins 0.000 claims description 4
• 102100025131 T-cell differentiation antigen CD6 Human genes 0.000 claims description 4
• 229920002477 rna polymer Polymers 0.000 claims description 4
• 108700024394 Exon Proteins 0.000 claims description 3
• 239000008194 pharmaceutical composition Substances 0.000 claims description 3
• 230000004075 alteration Effects 0.000 abstract description 13
• 239000002773 nucleotide Substances 0.000 description 176
• 239000002955 immunomodulating agent Substances 0.000 description 54
• 241000699670 Mus sp. Species 0.000 description 50
• 108020004414 DNA Proteins 0.000 description 42
• 102100039087 Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Human genes 0.000 description 35
• 238000004458 analytical method Methods 0.000 description 34
• 230000000694 effects Effects 0.000 description 31
• 210000001185 bone marrow Anatomy 0.000 description 30
• 238000000684 flow cytometry Methods 0.000 description 30
• 238000011282 treatment Methods 0.000 description 28
• 238000010362 genome editing Methods 0.000 description 27
• 235000018102 proteins Nutrition 0.000 description 25
• -1 CD45RA Proteins 0.000 description 22
• 235000001014 amino acid Nutrition 0.000 description 22
• 210000004369 blood Anatomy 0.000 description 22
• 239000008280 blood Substances 0.000 description 22
• 241000699666 Mus <mouse, genus> Species 0.000 description 19
• 230000004069 differentiation Effects 0.000 description 19
• 210000002865 immune cell Anatomy 0.000 description 19
• 108091028043 Nucleic acid sequence Proteins 0.000 description 18
• 238000013459 approach Methods 0.000 description 18
• 230000037442 genomic alteration Effects 0.000 description 18
• 238000009169 immunotherapy Methods 0.000 description 18
• 230000035899 viability Effects 0.000 description 18
• 108090000765 processed proteins & peptides Proteins 0.000 description 17
• 102100031780 Endonuclease Human genes 0.000 description 16
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 16
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 16
• 125000003275 alpha amino acid group Chemical group 0.000 description 16
• 229940024606 amino acid Drugs 0.000 description 16
• 150000001413 amino acids Chemical class 0.000 description 16
• 208000035475 disorder Diseases 0.000 description 16
• 210000000440 neutrophil Anatomy 0.000 description 16
• 108700004991 Cas12a Proteins 0.000 description 15
• 239000003814 drug Substances 0.000 description 15
• 239000012636 effector Substances 0.000 description 15
• 238000005516 engineering process Methods 0.000 description 14
• 101100220044 Homo sapiens CD34 gene Proteins 0.000 description 13
• 229920001184 polypeptide Polymers 0.000 description 13
• 102000004196 processed proteins & peptides Human genes 0.000 description 13
• 210000000952 spleen Anatomy 0.000 description 13
• 108010042407 Endonucleases Proteins 0.000 description 12
• 239000004698 Polyethylene Substances 0.000 description 12
• 102000004389 Ribonucleoproteins Human genes 0.000 description 12
• 108010081734 Ribonucleoproteins Proteins 0.000 description 12
• 210000003719 b-lymphocyte Anatomy 0.000 description 12
• 239000000047 product Substances 0.000 description 12
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 11
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 11
• 231100000135 cytotoxicity Toxicity 0.000 description 11
• 230000003013 cytotoxicity Effects 0.000 description 11
• 229940079593 drug Drugs 0.000 description 11
• 238000001727 in vivo Methods 0.000 description 11
• 239000002609 medium Substances 0.000 description 11
• 238000002360 preparation method Methods 0.000 description 11
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 10
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 10
• 241000193996 Streptococcus pyogenes Species 0.000 description 10
• 238000003776 cleavage reaction Methods 0.000 description 10
• 210000001616 monocyte Anatomy 0.000 description 10
• 210000000822 natural killer cell Anatomy 0.000 description 10
• 230000007017 scission Effects 0.000 description 10
• 230000011664 signaling Effects 0.000 description 10
• 241000894007 species Species 0.000 description 10
• 238000006467 substitution reaction Methods 0.000 description 10
• 210000001519 tissue Anatomy 0.000 description 10
• 239000003053 toxin Substances 0.000 description 10
• 231100000765 toxin Toxicity 0.000 description 10
• 108700012359 toxins Proteins 0.000 description 10
• 101100383038 Homo sapiens CD19 gene Proteins 0.000 description 9
• 230000002950 deficient Effects 0.000 description 9
• 238000010586 diagram Methods 0.000 description 9
• 238000000338 in vitro Methods 0.000 description 9
• 239000003446 ligand Substances 0.000 description 9
• 101000910035 Streptococcus pyogenes serotype M1 CRISPR-associated endonuclease Cas9/Csn1 Proteins 0.000 description 8
• 230000000139 costimulatory effect Effects 0.000 description 8
• 230000006870 function Effects 0.000 description 8
• 230000003394 haemopoietic effect Effects 0.000 description 8
• 230000028993 immune response Effects 0.000 description 8
• 230000001024 immunotherapeutic effect Effects 0.000 description 8
• 230000001225 therapeutic effect Effects 0.000 description 8
• 238000002560 therapeutic procedure Methods 0.000 description 8
• 208000005024 Castleman disease Diseases 0.000 description 7
• 102100031437 Cell cycle checkpoint protein RAD1 Human genes 0.000 description 7
• 101001130384 Homo sapiens Cell cycle checkpoint protein RAD1 Proteins 0.000 description 7
• 101001105486 Homo sapiens Proteasome subunit alpha type-7 Proteins 0.000 description 7
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 7
• 241001465754 Metazoa Species 0.000 description 7
• 102100021201 Proteasome subunit alpha type-7 Human genes 0.000 description 7
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 7
• 238000002659 cell therapy Methods 0.000 description 7
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 7
• 230000002147 killing effect Effects 0.000 description 7
• 238000012163 sequencing technique Methods 0.000 description 7
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 6
• 108091028113 Trans-activating crRNA Proteins 0.000 description 6
• 125000000539 amino acid group Chemical group 0.000 description 6
• 230000004071 biological effect Effects 0.000 description 6
• 230000001332 colony forming effect Effects 0.000 description 6
• 230000001627 detrimental effect Effects 0.000 description 6
• 238000002474 experimental method Methods 0.000 description 6
• 210000003714 granulocyte Anatomy 0.000 description 6
• 230000000670 limiting effect Effects 0.000 description 6
• 239000013642 negative control Substances 0.000 description 6
• 230000009437 off-target effect Effects 0.000 description 6
• 125000004430 oxygen atom Chemical group O* 0.000 description 6
• 230000002028 premature Effects 0.000 description 6
• 235000000346 sugar Nutrition 0.000 description 6
• 230000004083 survival effect Effects 0.000 description 6
• 238000010354 CRISPR gene editing Methods 0.000 description 5
• 102000053602 DNA Human genes 0.000 description 5
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 241000721454 Pemphigus Species 0.000 description 5
• 241000191967 Staphylococcus aureus Species 0.000 description 5
• 206010042971 T-cell lymphoma Diseases 0.000 description 5
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 5
• 108700019146 Transgenes Proteins 0.000 description 5
• 238000002617 apheresis Methods 0.000 description 5
• 238000003556 assay Methods 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 230000037396 body weight Effects 0.000 description 5
• 230000003833 cell viability Effects 0.000 description 5
• 238000009826 distribution Methods 0.000 description 5
• 210000003743 erythrocyte Anatomy 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 230000036961 partial effect Effects 0.000 description 5
• 230000002688 persistence Effects 0.000 description 5
• 238000010186 staining Methods 0.000 description 5
• 210000000603 stem cell niche Anatomy 0.000 description 5
• 210000001541 thymus gland Anatomy 0.000 description 5
• BXTJCSYMGFJEID-XMTADJHZSA-N (2s)-2-[[(2r,3r)-3-[(2s)-1-[(3r,4s,5s)-4-[[(2s)-2-[[(2s)-2-[6-[3-[(2r)-2-amino-2-carboxyethyl]sulfanyl-2,5-dioxopyrrolidin-1-yl]hexanoyl-methylamino]-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-met Chemical compound C([C@H](NC(=O)[C@H](C)[C@@H](OC)[C@@H]1CCCN1C(=O)C[C@H]([C@H]([C@@H](C)CC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(C(SC[C@H](N)C(O)=O)CC1=O)=O)C(C)C)OC)C(O)=O)C1=CC=CC=C1 BXTJCSYMGFJEID-XMTADJHZSA-N 0.000 description 4
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 4
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 4
• 102100033934 DNA repair protein RAD51 homolog 2 Human genes 0.000 description 4
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 4
• 101001132307 Homo sapiens DNA repair protein RAD51 homolog 2 Proteins 0.000 description 4
• 108060003951 Immunoglobulin Proteins 0.000 description 4
• 206010025323 Lymphomas Diseases 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 4
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
• 241000194020 Streptococcus thermophilus Species 0.000 description 4
• 208000000389 T-cell leukemia Diseases 0.000 description 4
• 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 4
• 208000026651 T-cell prolymphocytic leukemia Diseases 0.000 description 4
• IEDXPSOJFSVCKU-HOKPPMCLSA-N [4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[6-(2,5-dioxopyrrolidin-1-yl)hexanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methyl N-[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylcarbamate Chemical compound CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCCCCN2C(=O)CCC2=O)C(C)C)cc1)C(C)C IEDXPSOJFSVCKU-HOKPPMCLSA-N 0.000 description 4
• 230000002159 abnormal effect Effects 0.000 description 4
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
• 230000000735 allogeneic effect Effects 0.000 description 4
• 230000001363 autoimmune Effects 0.000 description 4
• 238000001574 biopsy Methods 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 210000000601 blood cell Anatomy 0.000 description 4
• 230000003197 catalytic effect Effects 0.000 description 4
• 230000008859 change Effects 0.000 description 4
• 238000012512 characterization method Methods 0.000 description 4
• 230000003750 conditioning effect Effects 0.000 description 4
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
• 230000034994 death Effects 0.000 description 4
• 238000011156 evaluation Methods 0.000 description 4
• 102000018358 immunoglobulin Human genes 0.000 description 4
• 210000002540 macrophage Anatomy 0.000 description 4
• 230000001404 mediated effect Effects 0.000 description 4
• 238000010172 mouse model Methods 0.000 description 4
• 210000005259 peripheral blood Anatomy 0.000 description 4
• 239000011886 peripheral blood Substances 0.000 description 4
• 238000001959 radiotherapy Methods 0.000 description 4
• 230000009467 reduction Effects 0.000 description 4
• 230000004044 response Effects 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 125000004434 sulfur atom Chemical group 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• 210000000689 upper leg Anatomy 0.000 description 4
• ZDTFMPXQUSBYRL-UUOKFMHZSA-N 2-Aminoadenosine Chemical compound C12=NC(N)=NC(N)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O ZDTFMPXQUSBYRL-UUOKFMHZSA-N 0.000 description 3
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 3
• 108700028369 Alleles Proteins 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 108091008875 B cell receptors Proteins 0.000 description 3
• 208000003950 B-cell lymphoma Diseases 0.000 description 3
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 3
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 3
• 102100027207 CD27 antigen Human genes 0.000 description 3
• 102100038078 CD276 antigen Human genes 0.000 description 3
• 101150013553 CD40 gene Proteins 0.000 description 3
• 108010065524 CD52 Antigen Proteins 0.000 description 3
• 102100025221 CD70 antigen Human genes 0.000 description 3
• 102100035793 CD83 antigen Human genes 0.000 description 3
• 102100025470 Carcinoembryonic antigen-related cell adhesion molecule 8 Human genes 0.000 description 3
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 3
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 3
• 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 3
• 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 3
• 208000007465 Giant cell arteritis Diseases 0.000 description 3
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 3
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 3
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 3
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 3
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 3
• 101000914320 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 8 Proteins 0.000 description 3
• 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 description 3
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 3
• 101001078143 Homo sapiens Integrin alpha-IIb Proteins 0.000 description 3
• 101001015004 Homo sapiens Integrin beta-3 Proteins 0.000 description 3
• 101000952182 Homo sapiens Max-like protein X Proteins 0.000 description 3
• 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 description 3
• 101000622137 Homo sapiens P-selectin Proteins 0.000 description 3
• 102100025306 Integrin alpha-IIb Human genes 0.000 description 3
• 102100032999 Integrin beta-3 Human genes 0.000 description 3
• 102100037423 Max-like protein X Human genes 0.000 description 3
• 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 description 3
• 108090000028 Neprilysin Proteins 0.000 description 3
• 102000003729 Neprilysin Human genes 0.000 description 3
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 3
• 102100023472 P-selectin Human genes 0.000 description 3
• 208000033759 Prolymphocytic T-Cell Leukemia Diseases 0.000 description 3
• 108010029485 Protein Isoforms Proteins 0.000 description 3
• 102000001708 Protein Isoforms Human genes 0.000 description 3
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 3
• 108091008874 T cell receptors Proteins 0.000 description 3
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 3
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 3
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 3
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• 230000002411 adverse Effects 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 210000001772 blood platelet Anatomy 0.000 description 3
• 210000002798 bone marrow cell Anatomy 0.000 description 3
• 230000024245 cell differentiation Effects 0.000 description 3
• 238000007385 chemical modification Methods 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 238000002648 combination therapy Methods 0.000 description 3
• 230000001086 cytosolic effect Effects 0.000 description 3
• 238000002784 cytotoxicity assay Methods 0.000 description 3
• 231100000263 cytotoxicity test Toxicity 0.000 description 3
• 210000004443 dendritic cell Anatomy 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 201000001981 dermatomyositis Diseases 0.000 description 3
• 210000003162 effector t lymphocyte Anatomy 0.000 description 3
• 230000001747 exhibiting effect Effects 0.000 description 3
• 238000010353 genetic engineering Methods 0.000 description 3
• 201000007162 hidradenitis suppurativa Diseases 0.000 description 3
• 238000013394 immunophenotyping Methods 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 238000002955 isolation Methods 0.000 description 3
• 206010025135 lupus erythematosus Diseases 0.000 description 3
• 208000020968 mature T-cell and NK-cell non-Hodgkin lymphoma Diseases 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 229960005558 mertansine Drugs 0.000 description 3
• 206010065579 multifocal motor neuropathy Diseases 0.000 description 3
• 210000003643 myeloid progenitor cell Anatomy 0.000 description 3
• 150000004713 phosphodiesters Chemical class 0.000 description 3
• 230000004962 physiological condition Effects 0.000 description 3
• 230000002062 proliferating effect Effects 0.000 description 3
• 230000000069 prophylactic effect Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 102000005962 receptors Human genes 0.000 description 3
• 108020003175 receptors Proteins 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 230000008439 repair process Effects 0.000 description 3
• 238000012552 review Methods 0.000 description 3
• 230000003007 single stranded DNA break Effects 0.000 description 3
• 208000024891 symptom Diseases 0.000 description 3
• 206010043207 temporal arteritis Diseases 0.000 description 3
• 229940124597 therapeutic agent Drugs 0.000 description 3
• ZAYHVCMSTBRABG-JXOAFFINSA-N 5-methylcytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZAYHVCMSTBRABG-JXOAFFINSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 2
• 229930024421 Adenine Natural products 0.000 description 2
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
• 208000016683 Adult T-cell leukemia/lymphoma Diseases 0.000 description 2
• 208000008190 Agammaglobulinemia Diseases 0.000 description 2
• 208000032671 Allergic granulomatous angiitis Diseases 0.000 description 2
• 102100022749 Aminopeptidase N Human genes 0.000 description 2
• 206010073478 Anaplastic large-cell lymphoma Diseases 0.000 description 2
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 description 2
• 208000004736 B-Cell Leukemia Diseases 0.000 description 2
• 238000011357 CAR T-cell therapy Methods 0.000 description 2
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 2
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
• 102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 description 2
• 206010068051 Chimerism Diseases 0.000 description 2
• 208000006344 Churg-Strauss Syndrome Diseases 0.000 description 2
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 2
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
• 208000021866 Dressler syndrome Diseases 0.000 description 2
• 206010064212 Eosinophilic oesophagitis Diseases 0.000 description 2
• 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 2
• 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 2
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 102100023849 Glycophorin-C Human genes 0.000 description 2
• 208000003084 Graves Ophthalmopathy Diseases 0.000 description 2
• 101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 description 2
• 101000884279 Homo sapiens CD276 antigen Proteins 0.000 description 2
• 101000623903 Homo sapiens Cell surface glycoprotein MUC18 Proteins 0.000 description 2
• 101000905336 Homo sapiens Glycophorin-C Proteins 0.000 description 2
• 101001076422 Homo sapiens Interleukin-1 receptor type 2 Proteins 0.000 description 2
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 2
• 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 description 2
• 101000610551 Homo sapiens Prominin-1 Proteins 0.000 description 2
• 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 description 2
• 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 description 2
• 206010020983 Hypogammaglobulinaemia Diseases 0.000 description 2
• 208000028622 Immune thrombocytopenia Diseases 0.000 description 2
• 102100022297 Integrin alpha-X Human genes 0.000 description 2
• 102100026017 Interleukin-1 receptor type 2 Human genes 0.000 description 2
• 208000005615 Interstitial Cystitis Diseases 0.000 description 2
• 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 2
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
• 208000032004 Large-Cell Anaplastic Lymphoma Diseases 0.000 description 2
• 241000713666 Lentivirus Species 0.000 description 2
• 208000012309 Linear IgA disease Diseases 0.000 description 2
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 2
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 2
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 2
• 208000003250 Mixed connective tissue disease Diseases 0.000 description 2
• 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 description 2
• 241000588649 Neisseria lactamica Species 0.000 description 2
• 208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 description 2
• 208000027190 Peripheral T-cell lymphomas Diseases 0.000 description 2
• 208000031845 Pernicious anaemia Diseases 0.000 description 2
• 102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 2
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 2
• 102100040678 Programmed cell death protein 1 Human genes 0.000 description 2
• 102100040120 Prominin-1 Human genes 0.000 description 2
• 208000003670 Pure Red-Cell Aplasia Diseases 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 208000005793 Restless legs syndrome Diseases 0.000 description 2
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
• 102100022433 Single-stranded DNA cytosine deaminase Human genes 0.000 description 2
• 101710143275 Single-stranded DNA cytosine deaminase Proteins 0.000 description 2
• 206010042276 Subacute endocarditis Diseases 0.000 description 2
• 206010042742 Sympathetic ophthalmia Diseases 0.000 description 2
• 102100035721 Syndecan-1 Human genes 0.000 description 2
• 208000031672 T-Cell Peripheral Lymphoma Diseases 0.000 description 2
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 2
• UHBPFYOQQPFKQR-JHEQGTHGSA-N Thr-Gln-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O UHBPFYOQQPFKQR-JHEQGTHGSA-N 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 2
• 206010043561 Thrombocytopenic purpura Diseases 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 206010051526 Tolosa-Hunt syndrome Diseases 0.000 description 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
• 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 description 2
• 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 2
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 2
• 208000025851 Undifferentiated connective tissue disease Diseases 0.000 description 2
• 208000017379 Undifferentiated connective tissue syndrome Diseases 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 229960000643 adenine Drugs 0.000 description 2
• 201000006966 adult T-cell leukemia Diseases 0.000 description 2
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
• 210000004102 animal cell Anatomy 0.000 description 2
• 230000000890 antigenic effect Effects 0.000 description 2
• 208000027625 autoimmune inner ear disease Diseases 0.000 description 2
• 210000003651 basophil Anatomy 0.000 description 2
• 239000011324 bead Substances 0.000 description 2
• 239000012472 biological sample Substances 0.000 description 2
• 229950007296 cantuzumab mertansine Drugs 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000006037 cell lysis Effects 0.000 description 2
• 230000012292 cell migration Effects 0.000 description 2
• 239000002458 cell surface marker Substances 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 239000013626 chemical specie Substances 0.000 description 2
• 108700010039 chimeric receptor Proteins 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
• 238000007796 conventional method Methods 0.000 description 2
• 238000005138 cryopreservation Methods 0.000 description 2
• 229940104302 cytosine Drugs 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 231100000371 dose-limiting toxicity Toxicity 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 210000003979 eosinophil Anatomy 0.000 description 2
• 201000000708 eosinophilic esophagitis Diseases 0.000 description 2
• 230000001973 epigenetic effect Effects 0.000 description 2
• 230000037433 frameshift Effects 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 238000003205 genotyping method Methods 0.000 description 2
• 229950009672 glembatumumab vedotin Drugs 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 208000018706 hematopoietic system disease Diseases 0.000 description 2
• 230000011132 hemopoiesis Effects 0.000 description 2
• 208000002557 hidradenitis Diseases 0.000 description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
• 230000005965 immune activity Effects 0.000 description 2
• 238000012744 immunostaining Methods 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 201000008319 inclusion body myositis Diseases 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 238000011835 investigation Methods 0.000 description 2
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
• 229960000310 isoleucine Drugs 0.000 description 2
• 238000005304 joining Methods 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 210000003738 lymphoid progenitor cell Anatomy 0.000 description 2
• ANZJBCHSOXCCRQ-FKUXLPTCSA-N mertansine Chemical compound CO[C@@H]([C@@]1(O)C[C@H](OC(=O)N1)[C@@H](C)[C@@H]1O[C@@]1(C)[C@@H](OC(=O)[C@H](C)N(C)C(=O)CCS)CC(=O)N1C)\C=C\C=C(C)\CC2=CC(OC)=C(Cl)C1=C2 ANZJBCHSOXCCRQ-FKUXLPTCSA-N 0.000 description 2
• 230000001394 metastastic effect Effects 0.000 description 2
• 206010061289 metastatic neoplasm Diseases 0.000 description 2
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
• 206010063344 microscopic polyangiitis Diseases 0.000 description 2
• 230000000116 mitigating effect Effects 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 210000000066 myeloid cell Anatomy 0.000 description 2
• 210000000581 natural killer T-cell Anatomy 0.000 description 2
• 230000001613 neoplastic effect Effects 0.000 description 2
• 208000008795 neuromyelitis optica Diseases 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 description 2
• 230000035935 pregnancy Effects 0.000 description 2
• 230000002265 prevention Effects 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 230000000306 recurrent effect Effects 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 230000001177 retroviral effect Effects 0.000 description 2
• 239000000523 sample Substances 0.000 description 2
• 230000009870 specific binding Effects 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 208000008467 subacute bacterial endocarditis Diseases 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• 210000002303 tibia Anatomy 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 238000010361 transduction Methods 0.000 description 2
• 230000026683 transduction Effects 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• 229960001612 trastuzumab emtansine Drugs 0.000 description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• 239000013598 vector Substances 0.000 description 2
• 231100000747 viability assay Toxicity 0.000 description 2
• 238000003026 viability measurement method Methods 0.000 description 2
• FBOUIAKEJMZPQG-AWNIVKPZSA-N (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol Chemical compound C1=NC=NN1/C(C(O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-AWNIVKPZSA-N 0.000 description 1
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• GJLXVWOMRRWCIB-MERZOTPQSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanamide Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=C(O)C=C1 GJLXVWOMRRWCIB-MERZOTPQSA-N 0.000 description 1
• RCSZIBSPHRZNRQ-BTZXMIIFSA-N (2S)-2-amino-6-[6-[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(2S)-3-(1H-indol-3-yl)-1-(oxazinan-2-yl)-1-oxopropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylamino]hexanoylamino]hexanoic acid Chemical compound OC(=O)[C@@H](N)CCCCNC(=O)CCCCCN(C)[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C(=O)N1OCCCC1)CC1=CNC2=CC=CC=C12 RCSZIBSPHRZNRQ-BTZXMIIFSA-N 0.000 description 1
• RIFDKYBNWNPCQK-IOSLPCCCSA-N (2r,3s,4r,5r)-2-(hydroxymethyl)-5-(6-imino-3-methylpurin-9-yl)oxolane-3,4-diol Chemical compound C1=2N(C)C=NC(=N)C=2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RIFDKYBNWNPCQK-IOSLPCCCSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• RKSLVDIXBGWPIS-UAKXSSHOSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 RKSLVDIXBGWPIS-UAKXSSHOSA-N 0.000 description 1
• QLOCVMVCRJOTTM-TURQNECASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 QLOCVMVCRJOTTM-TURQNECASA-N 0.000 description 1
• PISWNSOQFZRVJK-XLPZGREQSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-sulfanylidenepyrimidin-4-one Chemical compound S=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 PISWNSOQFZRVJK-XLPZGREQSA-N 0.000 description 1
• ZOHXWSHGANNQGO-DSIKUUPMSA-N 1-amino-4-[[5-[[(2S)-1-[[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-2-methyl-5-oxopentan-2-yl]disulfanyl]-1-oxobutane-2-sulfonic acid Chemical compound CO[C@@H]([C@@]1(O)C[C@H](OC(=O)N1)[C@@H](C)[C@@H]1O[C@@]1(C)[C@@H](OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)SSCCC(C(N)=O)S(O)(=O)=O)CC(=O)N1C)\C=C\C=C(C)\CC2=CC(OC)=C(Cl)C1=C2 ZOHXWSHGANNQGO-DSIKUUPMSA-N 0.000 description 1
• YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
• JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 1
• RHFUOMFWUGWKKO-XVFCMESISA-N 2-thiocytidine Chemical compound S=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RHFUOMFWUGWKKO-XVFCMESISA-N 0.000 description 1
• 108010082808 4-1BB Ligand Proteins 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• LMMLLWZHCKCFQA-UGKPPGOTSA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-prop-1-ynyloxolan-2-yl]pyrimidin-2-one Chemical compound C1=CC(N)=NC(=O)N1[C@]1(C#CC)O[C@H](CO)[C@@H](O)[C@H]1O LMMLLWZHCKCFQA-UGKPPGOTSA-N 0.000 description 1
• XXSIICQLPUAUDF-TURQNECASA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidin-2-one Chemical compound O=C1N=C(N)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 XXSIICQLPUAUDF-TURQNECASA-N 0.000 description 1
• CKTSBUTUHBMZGZ-ULQXZJNLSA-N 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-tritiopyrimidin-2-one Chemical compound O=C1N=C(N)C([3H])=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-ULQXZJNLSA-N 0.000 description 1
• 102100033400 4F2 cell-surface antigen heavy chain Human genes 0.000 description 1
• 102100022464 5'-nucleotidase Human genes 0.000 description 1
• ZAYHVCMSTBRABG-UHFFFAOYSA-N 5-Methylcytidine Natural products O=C1N=C(N)C(C)=CN1C1C(O)C(O)C(CO)O1 ZAYHVCMSTBRABG-UHFFFAOYSA-N 0.000 description 1
• AGFIRQJZCNVMCW-UAKXSSHOSA-N 5-bromouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 AGFIRQJZCNVMCW-UAKXSSHOSA-N 0.000 description 1
• FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 description 1
• KDOPAZIWBAHVJB-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]pyrimidine Chemical compound C1=NC=C2NC=CC2=N1 KDOPAZIWBAHVJB-UHFFFAOYSA-N 0.000 description 1
• BXJHWYVXLGLDMZ-UHFFFAOYSA-N 6-O-methylguanine Chemical compound COC1=NC(N)=NC2=C1NC=N2 BXJHWYVXLGLDMZ-UHFFFAOYSA-N 0.000 description 1
• UEHOMUNTZPIBIL-UUOKFMHZSA-N 6-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7h-purin-8-one Chemical compound O=C1NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O UEHOMUNTZPIBIL-UUOKFMHZSA-N 0.000 description 1
• HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 1
• HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 description 1
• 229940127148 AGS67E Drugs 0.000 description 1
• 102100033793 ALK tyrosine kinase receptor Human genes 0.000 description 1
• 241001430193 Absiella dolichum Species 0.000 description 1
• 241000093740 Acidaminococcus sp. Species 0.000 description 1
• 101000860090 Acidaminococcus sp. (strain BV3L6) CRISPR-associated endonuclease Cas12a Proteins 0.000 description 1
• 241001600124 Acidovorax avenae Species 0.000 description 1
• 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 1
• 241000948980 Actinobacillus succinogenes Species 0.000 description 1
• 241000606731 Actinobacillus suis Species 0.000 description 1
• 241001147825 Actinomyces sp. Species 0.000 description 1
• 208000026872 Addison Disease Diseases 0.000 description 1
• 108010052875 Adenine deaminase Proteins 0.000 description 1
• 102100026402 Adhesion G protein-coupled receptor E2 Human genes 0.000 description 1
• 102100026423 Adhesion G protein-coupled receptor E5 Human genes 0.000 description 1
• ZIBWKCRKNFYTPT-ZKWXMUAHSA-N Ala-Asn-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZIBWKCRKNFYTPT-ZKWXMUAHSA-N 0.000 description 1
• HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
• GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 1
• MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 1
• QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 1
• KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
• 206010001935 American trypanosomiasis Diseases 0.000 description 1
• 241001621924 Aminomonas paucivorans Species 0.000 description 1
• 208000028185 Angioedema Diseases 0.000 description 1
• 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 1
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
• 101001005269 Arabidopsis thaliana Ceramide synthase 1 LOH3 Proteins 0.000 description 1
• 101001005312 Arabidopsis thaliana Ceramide synthase LOH1 Proteins 0.000 description 1
• 101100124657 Arabidopsis thaliana HPCA1 gene Proteins 0.000 description 1
• XPSGESXVBSQZPL-SRVKXCTJSA-N Arg-Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XPSGESXVBSQZPL-SRVKXCTJSA-N 0.000 description 1
• LCBSSOCDWUTQQV-SDDRHHMPSA-N Arg-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LCBSSOCDWUTQQV-SDDRHHMPSA-N 0.000 description 1
• JWCCFNZJIRZUCL-AVGNSLFASA-N Arg-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N JWCCFNZJIRZUCL-AVGNSLFASA-N 0.000 description 1
• 206010003267 Arthritis reactive Diseases 0.000 description 1
• RAQMSGVCGSJKCL-FOHZUACHSA-N Asn-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(N)=O RAQMSGVCGSJKCL-FOHZUACHSA-N 0.000 description 1
• PQKSVQSMTHPRIB-ZKWXMUAHSA-N Asn-Val-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O PQKSVQSMTHPRIB-ZKWXMUAHSA-N 0.000 description 1
• AXXCUABIFZPKPM-BQBZGAKWSA-N Asp-Arg-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O AXXCUABIFZPKPM-BQBZGAKWSA-N 0.000 description 1
• YFSLJHLQOALGSY-ZPFDUUQYSA-N Asp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N YFSLJHLQOALGSY-ZPFDUUQYSA-N 0.000 description 1
• UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 102100022717 Atypical chemokine receptor 1 Human genes 0.000 description 1
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 1
• 206010064539 Autoimmune myocarditis Diseases 0.000 description 1
• 206010069002 Autoimmune pancreatitis Diseases 0.000 description 1
• 208000031212 Autoimmune polyendocrinopathy Diseases 0.000 description 1
• 102100025218 B-cell differentiation antigen CD72 Human genes 0.000 description 1
• 108010074708 B7-H1 Antigen Proteins 0.000 description 1
• MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 241000193755 Bacillus cereus Species 0.000 description 1
• 241000193399 Bacillus smithii Species 0.000 description 1
• 241000193388 Bacillus thuringiensis Species 0.000 description 1
• 241001148536 Bacteroides sp. Species 0.000 description 1
• 102100021264 Band 3 anion transport protein Human genes 0.000 description 1
• 102100028239 Basal cell adhesion molecule Human genes 0.000 description 1
• 102100032412 Basigin Human genes 0.000 description 1
• 208000027496 Behcet disease Diseases 0.000 description 1
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
• 208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
• 241000589957 Blastopirellula marina Species 0.000 description 1
• 102100037086 Bone marrow stromal antigen 2 Human genes 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 241000589171 Bradyrhizobium sp. Species 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 241000555281 Brevibacillus Species 0.000 description 1
• 241000193417 Brevibacillus laterosporus Species 0.000 description 1
• 102100022595 Broad substrate specificity ATP-binding cassette transporter ABCG2 Human genes 0.000 description 1
• 206010006811 Bursitis Diseases 0.000 description 1
• 102100027138 Butyrophilin subfamily 3 member A1 Human genes 0.000 description 1
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
• 102100036305 C-C chemokine receptor type 8 Human genes 0.000 description 1
• 102100036303 C-C chemokine receptor type 9 Human genes 0.000 description 1
• 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
• 102100032532 C-type lectin domain family 10 member A Human genes 0.000 description 1
• 102100028668 C-type lectin domain family 4 member C Human genes 0.000 description 1
• 102100028681 C-type lectin domain family 4 member K Human genes 0.000 description 1
• 102100040843 C-type lectin domain family 4 member M Human genes 0.000 description 1
• 102100025351 C-type mannose receptor 2 Human genes 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 102100032957 C5a anaphylatoxin chemotactic receptor 1 Human genes 0.000 description 1
• 102100037917 CD109 antigen Human genes 0.000 description 1
• 102100024263 CD160 antigen Human genes 0.000 description 1
• 108010009992 CD163 antigen Proteins 0.000 description 1
• 102100024210 CD166 antigen Human genes 0.000 description 1
• 102100021992 CD209 antigen Human genes 0.000 description 1
• 102100038077 CD226 antigen Human genes 0.000 description 1
• 101710185679 CD276 antigen Proteins 0.000 description 1
• 102100025238 CD302 antigen Human genes 0.000 description 1
• 102100025240 CD320 antigen Human genes 0.000 description 1
• 102000049320 CD36 Human genes 0.000 description 1
• 108010045374 CD36 Antigens Proteins 0.000 description 1
• 102100032937 CD40 ligand Human genes 0.000 description 1
• 102100032912 CD44 antigen Human genes 0.000 description 1
• 102100036008 CD48 antigen Human genes 0.000 description 1
• 102100022002 CD59 glycoprotein Human genes 0.000 description 1
• 102100025222 CD63 antigen Human genes 0.000 description 1
• 102100027221 CD81 antigen Human genes 0.000 description 1
• 102100027217 CD82 antigen Human genes 0.000 description 1
• 102000024905 CD99 Human genes 0.000 description 1
• 108060001253 CD99 Proteins 0.000 description 1
• ZCZQNDCUMLBKAG-MPVKSFTFSA-N CN([C@@H](C(C)C)C(=O)N[C@H](C(=O)N(C)[C@H]([C@@H](CC(=O)N1[C@@H](CCC1)[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(N)=O)OC)[C@@H](C)CC)C(C)C)CCCC(=O)NNC(=O)CCCCCN1C(=O)CC(SC[C@H](N)C(O)=O)C1=O Chemical compound CN([C@@H](C(C)C)C(=O)N[C@H](C(=O)N(C)[C@H]([C@@H](CC(=O)N1[C@@H](CCC1)[C@H](OC)[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(N)=O)OC)[C@@H](C)CC)C(C)C)CCCC(=O)NNC(=O)CCCCCN1C(=O)CC(SC[C@H](N)C(O)=O)C1=O ZCZQNDCUMLBKAG-MPVKSFTFSA-N 0.000 description 1
• 201000002829 CREST Syndrome Diseases 0.000 description 1
• 102100025805 Cadherin-1 Human genes 0.000 description 1
• 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 description 1
• 102100028801 Calsyntenin-1 Human genes 0.000 description 1
• 241000589877 Campylobacter coli Species 0.000 description 1
• 241000589875 Campylobacter jejuni Species 0.000 description 1
• 241000589986 Campylobacter lari Species 0.000 description 1
• 241000327159 Candidatus Puniceispirillum Species 0.000 description 1
• 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 description 1
• 102100025473 Carcinoembryonic antigen-related cell adhesion molecule 6 Human genes 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 102100037182 Cation-independent mannose-6-phosphate receptor Human genes 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 208000024699 Chagas disease Diseases 0.000 description 1
• 108091007741 Chimeric antigen receptor T cells Proteins 0.000 description 1
• 206010008609 Cholangitis sclerosing Diseases 0.000 description 1
• 102100031699 Choline transporter-like protein 1 Human genes 0.000 description 1
• 108010077544 Chromatin Proteins 0.000 description 1
• 241000193403 Clostridium Species 0.000 description 1
• 241000193468 Clostridium perfringens Species 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 208000015943 Coeliac disease Diseases 0.000 description 1
• 208000010007 Cogan syndrome Diseases 0.000 description 1
• 208000011038 Cold agglutinin disease Diseases 0.000 description 1
• 206010009868 Cold type haemolytic anaemia Diseases 0.000 description 1
• 206010009900 Colitis ulcerative Diseases 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 102100025877 Complement component C1q receptor Human genes 0.000 description 1
• 102100025680 Complement decay-accelerating factor Human genes 0.000 description 1
• 102100030886 Complement receptor type 1 Human genes 0.000 description 1
• 102100032768 Complement receptor type 2 Human genes 0.000 description 1
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 1
• 208000013586 Complex regional pain syndrome type 1 Diseases 0.000 description 1
• 206010010356 Congenital anomaly Diseases 0.000 description 1
• 206010010741 Conjunctivitis Diseases 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• 241001517050 Corynebacterium accolens Species 0.000 description 1
• 241000158496 Corynebacterium matruchotii Species 0.000 description 1
• 206010011258 Coxsackie myocarditis Diseases 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 208000019707 Cryoglobulinemic vasculitis Diseases 0.000 description 1
• GRNOCLDFUNCIDW-ACZMJKKPSA-N Cys-Ala-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N GRNOCLDFUNCIDW-ACZMJKKPSA-N 0.000 description 1
• NXQCSPVUPLUTJH-WHFBIAKZSA-N Cys-Ser-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O NXQCSPVUPLUTJH-WHFBIAKZSA-N 0.000 description 1
• 108010031325 Cytidine deaminase Proteins 0.000 description 1
• 102100039061 Cytokine receptor common subunit beta Human genes 0.000 description 1
• 102100026234 Cytokine receptor common subunit gamma Human genes 0.000 description 1
• 102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical class OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• 206010012468 Dermatitis herpetiformis Diseases 0.000 description 1
• 241001595867 Dinoroseobacter shibae Species 0.000 description 1
• 102100023471 E-selectin Human genes 0.000 description 1
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 1
• 102100036993 Ecto-ADP-ribosyltransferase 4 Human genes 0.000 description 1
• 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 description 1
• 102100037241 Endoglin Human genes 0.000 description 1
• 201000009273 Endometriosis Diseases 0.000 description 1
• 102100038083 Endosialin Human genes 0.000 description 1
• 208000002460 Enteropathy-Associated T-Cell Lymphoma Diseases 0.000 description 1
• 206010014954 Eosinophilic fasciitis Diseases 0.000 description 1
• 241000283073 Equus caballus Species 0.000 description 1
• 206010015226 Erythema nodosum Diseases 0.000 description 1
• 208000000289 Esophageal Achalasia Diseases 0.000 description 1
• 208000004332 Evans syndrome Diseases 0.000 description 1
• 108060002716 Exonuclease Proteins 0.000 description 1
• 102100031517 Fc receptor-like protein 1 Human genes 0.000 description 1
• 102100031511 Fc receptor-like protein 2 Human genes 0.000 description 1
• 102100031512 Fc receptor-like protein 3 Human genes 0.000 description 1
• 102100031513 Fc receptor-like protein 4 Human genes 0.000 description 1
• 102100031507 Fc receptor-like protein 5 Human genes 0.000 description 1
• 108010087819 Fc receptors Proteins 0.000 description 1
• 102000009109 Fc receptors Human genes 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 1
• 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 1
• 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 1
• 102100027844 Fibroblast growth factor receptor 4 Human genes 0.000 description 1
• 208000001640 Fibromyalgia Diseases 0.000 description 1
• 208000014770 Foot disease Diseases 0.000 description 1
• 241000589601 Francisella Species 0.000 description 1
• 101000860092 Francisella tularensis subsp. novicida (strain U112) CRISPR-associated endonuclease Cas12a Proteins 0.000 description 1
• 102100021261 Frizzled-10 Human genes 0.000 description 1
• 102100039820 Frizzled-4 Human genes 0.000 description 1
• 102100024405 GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Human genes 0.000 description 1
• 102100021260 Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Human genes 0.000 description 1
• 241000968725 Gammaproteobacteria bacterium Species 0.000 description 1
• 241000699694 Gerbillinae Species 0.000 description 1
• ODBLJLZVLAWVMS-GUBZILKMSA-N Gln-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N ODBLJLZVLAWVMS-GUBZILKMSA-N 0.000 description 1
• NROSLUJMIQGFKS-IUCAKERBSA-N Gln-His-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N NROSLUJMIQGFKS-IUCAKERBSA-N 0.000 description 1
• ARYKRXHBIPLULY-XKBZYTNZSA-N Gln-Thr-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ARYKRXHBIPLULY-XKBZYTNZSA-N 0.000 description 1
• 206010018364 Glomerulonephritis Diseases 0.000 description 1
• FYBSCGZLICNOBA-XQXXSGGOSA-N Glu-Ala-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FYBSCGZLICNOBA-XQXXSGGOSA-N 0.000 description 1
• UGSVSNXPJJDJKL-SDDRHHMPSA-N Glu-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N UGSVSNXPJJDJKL-SDDRHHMPSA-N 0.000 description 1
• 241001468096 Gluconacetobacter diazotrophicus Species 0.000 description 1
• 102100033366 Glutathione hydrolase 1 proenzyme Human genes 0.000 description 1
• PUUYVMYCMIWHFE-BQBZGAKWSA-N Gly-Ala-Arg Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PUUYVMYCMIWHFE-BQBZGAKWSA-N 0.000 description 1
• GRIRDMVMJJDZKV-RCOVLWMOSA-N Gly-Asn-Val Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O GRIRDMVMJJDZKV-RCOVLWMOSA-N 0.000 description 1
• PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 1
• MXIULRKNFSCJHT-STQMWFEESA-N Gly-Phe-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 MXIULRKNFSCJHT-STQMWFEESA-N 0.000 description 1
• LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 102100036430 Glycophorin-B Human genes 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 208000024869 Goodpasture syndrome Diseases 0.000 description 1
• 208000009329 Graft vs Host Disease Diseases 0.000 description 1
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
• 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 description 1
• 102100028113 Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Human genes 0.000 description 1
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 1
• 208000003807 Graves Disease Diseases 0.000 description 1
• 208000015023 Graves' disease Diseases 0.000 description 1
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 1
• 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 1
• 108010075704 HLA-A Antigens Proteins 0.000 description 1
• 108010010378 HLA-DP Antigens Proteins 0.000 description 1
• 102000015789 HLA-DP Antigens Human genes 0.000 description 1
• 108010062347 HLA-DQ Antigens Proteins 0.000 description 1
• 108010024164 HLA-G Antigens Proteins 0.000 description 1
• 108050008753 HNH endonucleases Proteins 0.000 description 1
• 102000000310 HNH endonucleases Human genes 0.000 description 1
• 241000606766 Haemophilus parainfluenzae Species 0.000 description 1
• 241000819598 Haemophilus sputorum Species 0.000 description 1
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
• 241000543133 Helicobacter canadensis Species 0.000 description 1
• 241000590014 Helicobacter cinaedi Species 0.000 description 1
• 241000590006 Helicobacter mustelae Species 0.000 description 1
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
• 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
• 102100038030 High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor Human genes 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101000800023 Homo sapiens 4F2 cell-surface antigen heavy chain Proteins 0.000 description 1
• 101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
• 101000718243 Homo sapiens Adhesion G protein-coupled receptor E5 Proteins 0.000 description 1
• 101000773743 Homo sapiens Angiotensin-converting enzyme Proteins 0.000 description 1
• 101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 description 1
• 101000716063 Homo sapiens C-C chemokine receptor type 8 Proteins 0.000 description 1
• 101000716070 Homo sapiens C-C chemokine receptor type 9 Proteins 0.000 description 1
• 101000912622 Homo sapiens C-type lectin domain family 12 member A Proteins 0.000 description 1
• 101000766907 Homo sapiens C-type lectin domain family 4 member C Proteins 0.000 description 1
• 101000749311 Homo sapiens C-type lectin domain family 4 member M Proteins 0.000 description 1
• 101000576898 Homo sapiens C-type mannose receptor 2 Proteins 0.000 description 1
• 101000867983 Homo sapiens C5a anaphylatoxin chemotactic receptor 1 Proteins 0.000 description 1
• 101000761938 Homo sapiens CD160 antigen Proteins 0.000 description 1
• 101000980845 Homo sapiens CD177 antigen Proteins 0.000 description 1
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
• 101000716130 Homo sapiens CD48 antigen Proteins 0.000 description 1
• 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
• 101000934368 Homo sapiens CD63 antigen Proteins 0.000 description 1
• 101000914479 Homo sapiens CD81 antigen Proteins 0.000 description 1
• 101000914469 Homo sapiens CD82 antigen Proteins 0.000 description 1
• 101000981093 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 1 Proteins 0.000 description 1
• 101000914326 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 6 Proteins 0.000 description 1
• 101000940912 Homo sapiens Choline transporter-like protein 1 Proteins 0.000 description 1
• 101000933665 Homo sapiens Complement component C1q receptor Proteins 0.000 description 1
• 101000856022 Homo sapiens Complement decay-accelerating factor Proteins 0.000 description 1
• 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 description 1
• 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 description 1
• 101000622123 Homo sapiens E-selectin Proteins 0.000 description 1
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
• 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 description 1
• 101000846913 Homo sapiens Fc receptor-like protein 1 Proteins 0.000 description 1
• 101000846911 Homo sapiens Fc receptor-like protein 2 Proteins 0.000 description 1
• 101000846910 Homo sapiens Fc receptor-like protein 3 Proteins 0.000 description 1
• 101000846909 Homo sapiens Fc receptor-like protein 4 Proteins 0.000 description 1
• 101000846908 Homo sapiens Fc receptor-like protein 5 Proteins 0.000 description 1
• 101000827688 Homo sapiens Fibroblast growth factor receptor 2 Proteins 0.000 description 1
• 101000894906 Homo sapiens Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 Proteins 0.000 description 1
• 101001071776 Homo sapiens Glycophorin-B Proteins 0.000 description 1
• 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 1
• 101001081176 Homo sapiens Hyaluronan mediated motility receptor Proteins 0.000 description 1
• 101000878602 Homo sapiens Immunoglobulin alpha Fc receptor Proteins 0.000 description 1
• 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 description 1
• 101001078158 Homo sapiens Integrin alpha-1 Proteins 0.000 description 1
• 101001078133 Homo sapiens Integrin alpha-2 Proteins 0.000 description 1
• 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 description 1
• 101000994369 Homo sapiens Integrin alpha-5 Proteins 0.000 description 1
• 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 description 1
• 101001035237 Homo sapiens Integrin alpha-D Proteins 0.000 description 1
• 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 description 1
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 1
• 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 1
• 101000599862 Homo sapiens Intercellular adhesion molecule 3 Proteins 0.000 description 1
• 101001001420 Homo sapiens Interferon gamma receptor 1 Proteins 0.000 description 1
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
• 101001083151 Homo sapiens Interleukin-10 receptor subunit alpha Proteins 0.000 description 1
• 101001003135 Homo sapiens Interleukin-13 receptor subunit alpha-1 Proteins 0.000 description 1
• 101001003132 Homo sapiens Interleukin-13 receptor subunit alpha-2 Proteins 0.000 description 1
• 101000961065 Homo sapiens Interleukin-18 receptor 1 Proteins 0.000 description 1
• 101001019615 Homo sapiens Interleukin-18 receptor accessory protein Proteins 0.000 description 1
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
• 101000945371 Homo sapiens Killer cell immunoglobulin-like receptor 2DL2 Proteins 0.000 description 1
• 101001049181 Homo sapiens Killer cell lectin-like receptor subfamily B member 1 Proteins 0.000 description 1
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 1
• 101000605020 Homo sapiens Large neutral amino acids transporter small subunit 1 Proteins 0.000 description 1
• 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 description 1
• 101000984189 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 2 Proteins 0.000 description 1
• 101000984186 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 4 Proteins 0.000 description 1
• 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 description 1
• 101000980823 Homo sapiens Leukocyte surface antigen CD53 Proteins 0.000 description 1
• 101000608935 Homo sapiens Leukosialin Proteins 0.000 description 1
• 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 description 1
• 101001023379 Homo sapiens Lysosome-associated membrane glycoprotein 1 Proteins 0.000 description 1
• 101000604993 Homo sapiens Lysosome-associated membrane glycoprotein 2 Proteins 0.000 description 1
• 101000991061 Homo sapiens MHC class I polypeptide-related sequence B Proteins 0.000 description 1
• 101000576894 Homo sapiens Macrophage mannose receptor 1 Proteins 0.000 description 1
• 101000934372 Homo sapiens Macrosialin Proteins 0.000 description 1
• 101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 description 1
• 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 1
• 101100460850 Homo sapiens NCR3LG1 gene Proteins 0.000 description 1
• 101001109508 Homo sapiens NKG2-A/NKG2-B type II integral membrane protein Proteins 0.000 description 1
• 101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 description 1
• 101001051490 Homo sapiens Neural cell adhesion molecule L1 Proteins 0.000 description 1
• 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 description 1
• 101000897042 Homo sapiens Nucleotide pyrophosphatase Proteins 0.000 description 1
• 101001071312 Homo sapiens Platelet glycoprotein IX Proteins 0.000 description 1
• 101001070790 Homo sapiens Platelet glycoprotein Ib alpha chain Proteins 0.000 description 1
• 101001070786 Homo sapiens Platelet glycoprotein Ib beta chain Proteins 0.000 description 1
• 101001033026 Homo sapiens Platelet glycoprotein V Proteins 0.000 description 1
• 101001126417 Homo sapiens Platelet-derived growth factor receptor alpha Proteins 0.000 description 1
• 101000692455 Homo sapiens Platelet-derived growth factor receptor beta Proteins 0.000 description 1
• 101001043564 Homo sapiens Prolow-density lipoprotein receptor-related protein 1 Proteins 0.000 description 1
• 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 description 1
• 101001136981 Homo sapiens Proteasome subunit beta type-9 Proteins 0.000 description 1
• 101001100327 Homo sapiens RNA-binding protein 45 Proteins 0.000 description 1
• 101001062222 Homo sapiens Receptor-binding cancer antigen expressed on SiSo cells Proteins 0.000 description 1
• 101000633778 Homo sapiens SLAM family member 5 Proteins 0.000 description 1
• 101000863900 Homo sapiens Sialic acid-binding Ig-like lectin 5 Proteins 0.000 description 1
• 101000868472 Homo sapiens Sialoadhesin Proteins 0.000 description 1
• 101001133085 Homo sapiens Sialomucin core protein 24 Proteins 0.000 description 1
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
• 101000709256 Homo sapiens Signal-regulatory protein beta-1 Proteins 0.000 description 1
• 101000709188 Homo sapiens Signal-regulatory protein beta-1 isoform 3 Proteins 0.000 description 1
• 101000835928 Homo sapiens Signal-regulatory protein gamma Proteins 0.000 description 1
• 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 description 1
• 101100207070 Homo sapiens TNFSF8 gene Proteins 0.000 description 1
• 101000763314 Homo sapiens Thrombomodulin Proteins 0.000 description 1
• 101000635804 Homo sapiens Tissue factor Proteins 0.000 description 1
• 101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
• 101000801232 Homo sapiens Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 1
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
• 101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 1
• 101000863873 Homo sapiens Tyrosine-protein phosphatase non-receptor type substrate 1 Proteins 0.000 description 1
• 101000760337 Homo sapiens Urokinase plasminogen activator surface receptor Proteins 0.000 description 1
• 102100027735 Hyaluronan mediated motility receptor Human genes 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 1
• 208000010159 IgA glomerulonephritis Diseases 0.000 description 1
• 206010021263 IgA nephropathy Diseases 0.000 description 1
• 208000021330 IgG4-related disease Diseases 0.000 description 1
• 208000014919 IgG4-related retroperitoneal fibrosis Diseases 0.000 description 1
• FVEWRQXNISSYFO-ZPFDUUQYSA-N Ile-Arg-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FVEWRQXNISSYFO-ZPFDUUQYSA-N 0.000 description 1
• PPSQSIDMOVPKPI-BJDJZHNGSA-N Ile-Cys-Leu Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O PPSQSIDMOVPKPI-BJDJZHNGSA-N 0.000 description 1
• GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 1
• 241000411974 Ilyobacter polytropus Species 0.000 description 1
• 208000031781 Immunoglobulin G4 related sclerosing disease Diseases 0.000 description 1
• 208000004187 Immunoglobulin G4-Related Disease Diseases 0.000 description 1
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
• 102100038005 Immunoglobulin alpha Fc receptor Human genes 0.000 description 1
• 102100022516 Immunoglobulin superfamily member 2 Human genes 0.000 description 1
• 102100036489 Immunoglobulin superfamily member 8 Human genes 0.000 description 1
• 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 description 1
• 102100021317 Inducible T-cell costimulator Human genes 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 102100036721 Insulin receptor Human genes 0.000 description 1
• 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 1
• 102100034343 Integrase Human genes 0.000 description 1
• 108010061833 Integrases Proteins 0.000 description 1
• 102100025323 Integrin alpha-1 Human genes 0.000 description 1
• 102100025305 Integrin alpha-2 Human genes 0.000 description 1
• 102100032818 Integrin alpha-4 Human genes 0.000 description 1
• 102100032817 Integrin alpha-5 Human genes 0.000 description 1
• 102100032816 Integrin alpha-6 Human genes 0.000 description 1
• 102100039904 Integrin alpha-D Human genes 0.000 description 1
• 102100022341 Integrin alpha-E Human genes 0.000 description 1
• 102100022337 Integrin alpha-V Human genes 0.000 description 1
• 102100025304 Integrin beta-1 Human genes 0.000 description 1
• 102100025390 Integrin beta-2 Human genes 0.000 description 1
• 102100033000 Integrin beta-4 Human genes 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 description 1
• 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 1
• 102100035678 Interferon gamma receptor 1 Human genes 0.000 description 1
• 102100040021 Interferon-induced transmembrane protein 1 Human genes 0.000 description 1
• 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 1
• 102100030236 Interleukin-10 receptor subunit alpha Human genes 0.000 description 1
• 102100020790 Interleukin-12 receptor subunit beta-1 Human genes 0.000 description 1
• 102100020791 Interleukin-13 receptor subunit alpha-1 Human genes 0.000 description 1
• 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 description 1
• 102100020789 Interleukin-15 receptor subunit alpha Human genes 0.000 description 1
• 102100035018 Interleukin-17 receptor A Human genes 0.000 description 1
• 102100039340 Interleukin-18 receptor 1 Human genes 0.000 description 1
• 102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 description 1
• 102100030699 Interleukin-21 receptor Human genes 0.000 description 1
• 102100039078 Interleukin-4 receptor subunit alpha Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102000000743 Interleukin-5 Human genes 0.000 description 1
• 102100039881 Interleukin-5 receptor subunit alpha Human genes 0.000 description 1
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 1
• 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 1
• 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 description 1
• 102100026244 Interleukin-9 receptor Human genes 0.000 description 1
• 206010022557 Intermediate uveitis Diseases 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 108020003285 Isocitrate lyase Proteins 0.000 description 1
• PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
• 102100022304 Junctional adhesion molecule A Human genes 0.000 description 1
• 102100023430 Junctional adhesion molecule B Human genes 0.000 description 1
• 208000003456 Juvenile Arthritis Diseases 0.000 description 1
• 208000011200 Kawasaki disease Diseases 0.000 description 1
• 102100021447 Kell blood group glycoprotein Human genes 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 102100033599 Killer cell immunoglobulin-like receptor 2DL2 Human genes 0.000 description 1
• 102100023678 Killer cell lectin-like receptor subfamily B member 1 Human genes 0.000 description 1
• 241000589014 Kingella kingae Species 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• 102100033467 L-selectin Human genes 0.000 description 1
• 239000005511 L01XE05 - Sorafenib Substances 0.000 description 1
• 102000017578 LAG3 Human genes 0.000 description 1
• 241000904817 Lachnospiraceae bacterium Species 0.000 description 1
• 241000218492 Lactobacillus crispatus Species 0.000 description 1
• 201000010743 Lambert-Eaton myasthenic syndrome Diseases 0.000 description 1
• 208000006404 Large Granular Lymphocytic Leukemia Diseases 0.000 description 1
• 241000880493 Leptailurus serval Species 0.000 description 1
• 102100031775 Leptin receptor Human genes 0.000 description 1
• ZURHXHNAEJJRNU-CIUDSAMLSA-N Leu-Asp-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZURHXHNAEJJRNU-CIUDSAMLSA-N 0.000 description 1
• PPBKJAQJAUHZKX-SRVKXCTJSA-N Leu-Cys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CC(C)C PPBKJAQJAUHZKX-SRVKXCTJSA-N 0.000 description 1
• XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
• CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 1
• XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 1
• SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 1
• SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 1
• FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102100031586 Leukocyte antigen CD37 Human genes 0.000 description 1
• 102100025583 Leukocyte immunoglobulin-like receptor subfamily B member 2 Human genes 0.000 description 1
• 102100025578 Leukocyte immunoglobulin-like receptor subfamily B member 4 Human genes 0.000 description 1
• 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 description 1
• 102100024221 Leukocyte surface antigen CD53 Human genes 0.000 description 1
• 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 description 1
• 102100020858 Leukocyte-associated immunoglobulin-like receptor 2 Human genes 0.000 description 1
• 102100039564 Leukosialin Human genes 0.000 description 1
• 206010024434 Lichen sclerosus Diseases 0.000 description 1
• 241000186780 Listeria ivanovii Species 0.000 description 1
• 241000186779 Listeria monocytogenes Species 0.000 description 1
• 241001112727 Listeriaceae Species 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 102100033486 Lymphocyte antigen 75 Human genes 0.000 description 1
• 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 description 1
• 102000018170 Lymphotoxin beta Receptor Human genes 0.000 description 1
• 108010091221 Lymphotoxin beta Receptor Proteins 0.000 description 1
• YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 description 1
• 102100038225 Lysosome-associated membrane glycoprotein 2 Human genes 0.000 description 1
• 102100038213 Lysosome-associated membrane glycoprotein 3 Human genes 0.000 description 1
• 102100030301 MHC class I polypeptide-related sequence A Human genes 0.000 description 1
• 102100030300 MHC class I polypeptide-related sequence B Human genes 0.000 description 1
• 102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 1
• 102100025354 Macrophage mannose receptor 1 Human genes 0.000 description 1
• 102100034184 Macrophage scavenger receptor types I and II Human genes 0.000 description 1
• 102100021435 Macrophage-stimulating protein receptor Human genes 0.000 description 1
• 102100025136 Macrosialin Human genes 0.000 description 1
• 102100025818 Major prion protein Human genes 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 208000025205 Mantle-Cell Lymphoma Diseases 0.000 description 1
• 102100039373 Membrane cofactor protein Human genes 0.000 description 1
• 208000027530 Meniere disease Diseases 0.000 description 1
• USBFEVBHEQBWDD-AVGNSLFASA-N Met-Leu-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O USBFEVBHEQBWDD-AVGNSLFASA-N 0.000 description 1
• 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 1
• 241000945786 Methylocystis sp. Species 0.000 description 1
• 241000589351 Methylosinus trichosporium Species 0.000 description 1
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
• 241000203732 Mobiluncus mulieris Species 0.000 description 1
• 241000204801 Muraenidae Species 0.000 description 1
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
• 101100207071 Mus musculus Tnfsf8 gene Proteins 0.000 description 1
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
• 201000002481 Myositis Diseases 0.000 description 1
• SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
• XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
• 102100022682 NKG2-A/NKG2-B type II integral membrane protein Human genes 0.000 description 1
• 102100032851 Natural cytotoxicity triggering receptor 2 Human genes 0.000 description 1
• 102100032852 Natural cytotoxicity triggering receptor 3 Human genes 0.000 description 1
• 102100029527 Natural cytotoxicity triggering receptor 3 ligand 1 Human genes 0.000 description 1
• 102100021462 Natural killer cells antigen CD94 Human genes 0.000 description 1
• 102100023064 Nectin-1 Human genes 0.000 description 1
• 102100035488 Nectin-2 Human genes 0.000 description 1
• 102100035487 Nectin-3 Human genes 0.000 description 1
• 241000109432 Neisseria bacilliformis Species 0.000 description 1
• 241000588654 Neisseria cinerea Species 0.000 description 1
• 241000588651 Neisseria flavescens Species 0.000 description 1
• 241000588650 Neisseria meningitidis Species 0.000 description 1
• 241001440871 Neisseria sp. Species 0.000 description 1
• 241000086765 Neisseria wadsworthii Species 0.000 description 1
• 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 description 1
• 206010071579 Neuronal neuropathy Diseases 0.000 description 1
• 102100028762 Neuropilin-1 Human genes 0.000 description 1
• 241000143395 Nitrosomonas sp. Species 0.000 description 1
• 102100021969 Nucleotide pyrophosphatase Human genes 0.000 description 1
• 102100037589 OX-2 membrane glycoprotein Human genes 0.000 description 1
• 108010042215 OX40 Ligand Proteins 0.000 description 1
• 206010030136 Oesophageal achalasia Diseases 0.000 description 1
• 208000003435 Optic Neuritis Diseases 0.000 description 1
• 206010031252 Osteomyelitis Diseases 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 208000025174 PANDAS Diseases 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 206010053869 POEMS syndrome Diseases 0.000 description 1
• 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 240000000220 Panda oleosa Species 0.000 description 1
• 235000016496 Panda oleosa Nutrition 0.000 description 1
• 241001386755 Parvibaculum lavamentivorans Species 0.000 description 1
• 241000606856 Pasteurella multocida Species 0.000 description 1
• 206010034277 Pemphigoid Diseases 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 241000009328 Perro Species 0.000 description 1
• 241000801571 Phascolarctobacterium succinatutens Species 0.000 description 1
• PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 1
• YMIZSYUAZJSOFL-SRVKXCTJSA-N Phe-Ser-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O YMIZSYUAZJSOFL-SRVKXCTJSA-N 0.000 description 1
• GNRMAQSIROFNMI-IXOXFDKPSA-N Phe-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GNRMAQSIROFNMI-IXOXFDKPSA-N 0.000 description 1
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
• 102100036851 Platelet glycoprotein IX Human genes 0.000 description 1
• 102100034173 Platelet glycoprotein Ib alpha chain Human genes 0.000 description 1
• 102100034168 Platelet glycoprotein Ib beta chain Human genes 0.000 description 1
• 102100038411 Platelet glycoprotein V Human genes 0.000 description 1
• 102100030485 Platelet-derived growth factor receptor alpha Human genes 0.000 description 1
• 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 description 1
• 102100035381 Plexin-C1 Human genes 0.000 description 1
• 102100029740 Poliovirus receptor Human genes 0.000 description 1
• 206010065159 Polychondritis Diseases 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 208000007048 Polymyalgia Rheumatica Diseases 0.000 description 1
• 208000031732 Post-Lyme Disease Syndrome Diseases 0.000 description 1
• 208000004347 Postpericardiotomy Syndrome Diseases 0.000 description 1
• 208000012654 Primary biliary cholangitis Diseases 0.000 description 1
• AJJDPGVVNPUZCR-RHYQMDGZSA-N Pro-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1)O AJJDPGVVNPUZCR-RHYQMDGZSA-N 0.000 description 1
• FIODMZKLZFLYQP-GUBZILKMSA-N Pro-Val-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FIODMZKLZFLYQP-GUBZILKMSA-N 0.000 description 1
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 1
• 101710089372 Programmed cell death protein 1 Proteins 0.000 description 1
• 208000037534 Progressive hemifacial atrophy Diseases 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 102100021923 Prolow-density lipoprotein receptor-related protein 1 Human genes 0.000 description 1
• 102100024218 Prostaglandin D2 receptor 2 Human genes 0.000 description 1
• 102100020864 Prostaglandin F2 receptor negative regulator Human genes 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 102100036735 Prostate stem cell antigen Human genes 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 102100035764 Proteasome subunit beta type-9 Human genes 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 102100032702 Protein jagged-1 Human genes 0.000 description 1
• 201000004681 Psoriasis Diseases 0.000 description 1
• 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
• 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
• 206010037549 Purpura Diseases 0.000 description 1
• 241001672981 Purpura Species 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 102100038823 RNA-binding protein 45 Human genes 0.000 description 1
• 241001135508 Ralstonia syzygii Species 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 208000012322 Raynaud phenomenon Diseases 0.000 description 1
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
• 102100029165 Receptor-binding cancer antigen expressed on SiSo cells Human genes 0.000 description 1
• 102100039808 Receptor-type tyrosine-protein phosphatase eta Human genes 0.000 description 1
• 201000001947 Reflex Sympathetic Dystrophy Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 206010038979 Retroperitoneal fibrosis Diseases 0.000 description 1
• 241000190950 Rhodopseudomonas palustris Species 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 102100029216 SLAM family member 5 Human genes 0.000 description 1
• 102100029197 SLAM family member 6 Human genes 0.000 description 1
• 102100029198 SLAM family member 7 Human genes 0.000 description 1
• 102100029214 SLAM family member 8 Human genes 0.000 description 1
• 102100025831 Scavenger receptor cysteine-rich type 1 protein M130 Human genes 0.000 description 1
• 206010039705 Scleritis Diseases 0.000 description 1
• 206010039710 Scleroderma Diseases 0.000 description 1
• 102100027744 Semaphorin-4D Human genes 0.000 description 1
• 102100037545 Semaphorin-7A Human genes 0.000 description 1
• IUXGJEIKJBYKOO-SRVKXCTJSA-N Ser-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N IUXGJEIKJBYKOO-SRVKXCTJSA-N 0.000 description 1
• CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 1
• NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
• LLSLRQOEAFCZLW-NRPADANISA-N Ser-Val-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LLSLRQOEAFCZLW-NRPADANISA-N 0.000 description 1
• MFQMZDPAZRZAPV-NAKRPEOUSA-N Ser-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N MFQMZDPAZRZAPV-NAKRPEOUSA-N 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 102100029957 Sialic acid-binding Ig-like lectin 5 Human genes 0.000 description 1
• 102100029947 Sialic acid-binding Ig-like lectin 6 Human genes 0.000 description 1
• 102100029946 Sialic acid-binding Ig-like lectin 7 Human genes 0.000 description 1
• 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 description 1
• 102100032855 Sialoadhesin Human genes 0.000 description 1
• 102100034258 Sialomucin core protein 24 Human genes 0.000 description 1
• 102100038081 Signal transducer CD24 Human genes 0.000 description 1
• 102100032770 Signal-regulatory protein beta-1 isoform 3 Human genes 0.000 description 1
• 102100025795 Signal-regulatory protein gamma Human genes 0.000 description 1
• 102100029215 Signaling lymphocytic activation molecule Human genes 0.000 description 1
• 241000863010 Simonsiella muelleri Species 0.000 description 1
• 208000021386 Sjogren Syndrome Diseases 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 102100022792 Sodium/potassium-transporting ATPase subunit beta-3 Human genes 0.000 description 1
• 241001135759 Sphingomonas sp. Species 0.000 description 1
• 101000668858 Spinacia oleracea 30S ribosomal protein S1, chloroplastic Proteins 0.000 description 1
• 241000439819 Sporolactobacillus vineae Species 0.000 description 1
• 241001134656 Staphylococcus lugdunensis Species 0.000 description 1
• 241000194022 Streptococcus sp. Species 0.000 description 1
• 101000898746 Streptomyces clavuligerus Clavaminate synthase 1 Proteins 0.000 description 1
• 241001037423 Subdoligranulum sp. Species 0.000 description 1
• 108091027544 Subgenomic mRNA Proteins 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 208000002286 Susac Syndrome Diseases 0.000 description 1
• 208000031673 T-Cell Cutaneous Lymphoma Diseases 0.000 description 1
• 206010042970 T-cell chronic lymphocytic leukaemia Diseases 0.000 description 1
• 201000008717 T-cell large granular lymphocyte leukemia Diseases 0.000 description 1
• 102100036014 T-cell surface glycoprotein CD1c Human genes 0.000 description 1
• 102100035268 T-cell surface protein tactile Human genes 0.000 description 1
• 102100033447 T-lymphocyte surface antigen Ly-9 Human genes 0.000 description 1
• 208000001106 Takayasu Arteritis Diseases 0.000 description 1
• 101001051488 Takifugu rubripes Neural cell adhesion molecule L1 Proteins 0.000 description 1
• 206010071574 Testicular autoimmunity Diseases 0.000 description 1
• 102100040952 Tetraspanin-7 Human genes 0.000 description 1
• 238000012338 Therapeutic targeting Methods 0.000 description 1
• CTONFVDJYCAMQM-IUKAMOBKSA-N Thr-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)N CTONFVDJYCAMQM-IUKAMOBKSA-N 0.000 description 1
• OJRNZRROAIAHDL-LKXGYXEUSA-N Thr-Asn-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OJRNZRROAIAHDL-LKXGYXEUSA-N 0.000 description 1
• XOTBWOCSLMBGMF-SUSMZKCASA-N Thr-Glu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XOTBWOCSLMBGMF-SUSMZKCASA-N 0.000 description 1
• XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 1
• AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
• WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 1
• IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 1
• BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 1
• ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 1
• ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 1
• COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 1
• PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 1
• SPIFGZFZMVLPHN-UNQGMJICSA-N Thr-Val-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SPIFGZFZMVLPHN-UNQGMJICSA-N 0.000 description 1
• 102100026966 Thrombomodulin Human genes 0.000 description 1
• 102100034196 Thrombopoietin receptor Human genes 0.000 description 1
• 102100030859 Tissue factor Human genes 0.000 description 1
• 241000694894 Tistrella mobilis Species 0.000 description 1
• 102100027010 Toll-like receptor 1 Human genes 0.000 description 1
• 102100027009 Toll-like receptor 10 Human genes 0.000 description 1
• 102100024333 Toll-like receptor 2 Human genes 0.000 description 1
• 102100024324 Toll-like receptor 3 Human genes 0.000 description 1
• 102100039360 Toll-like receptor 4 Human genes 0.000 description 1
• 102100039387 Toll-like receptor 6 Human genes 0.000 description 1
• 102100033110 Toll-like receptor 8 Human genes 0.000 description 1
• 102100033117 Toll-like receptor 9 Human genes 0.000 description 1
• 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 1
• 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 1
• 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 1
• 241000589906 Treponema sp. Species 0.000 description 1
• 102100029681 Triggering receptor expressed on myeloid cells 1 Human genes 0.000 description 1
• YCQXZDHDSUHUSG-FJHTZYQYSA-N Trp-Thr-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 YCQXZDHDSUHUSG-FJHTZYQYSA-N 0.000 description 1
• 241000223109 Trypanosoma cruzi Species 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 1
• 102100024585 Tumor necrosis factor ligand superfamily member 13 Human genes 0.000 description 1
• 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 1
• 102100024586 Tumor necrosis factor ligand superfamily member 14 Human genes 0.000 description 1
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 1
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 description 1
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 1
• 102100040115 Tumor necrosis factor receptor superfamily member 10C Human genes 0.000 description 1
• 102100040110 Tumor necrosis factor receptor superfamily member 10D Human genes 0.000 description 1
• 102100028787 Tumor necrosis factor receptor superfamily member 11A Human genes 0.000 description 1
• 102100028786 Tumor necrosis factor receptor superfamily member 12A Human genes 0.000 description 1
• 102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 description 1
• 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 description 1
• 102100033726 Tumor necrosis factor receptor superfamily member 17 Human genes 0.000 description 1
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
• 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 1
• 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 1
• 102100022205 Tumor necrosis factor receptor superfamily member 21 Human genes 0.000 description 1
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
• 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 1
• 208000026928 Turner syndrome Diseases 0.000 description 1
• IYHNBRUWVBIVJR-IHRRRGAJSA-N Tyr-Gln-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 IYHNBRUWVBIVJR-IHRRRGAJSA-N 0.000 description 1
• CDHQEOXPWBDFPL-QWRGUYRKSA-N Tyr-Gly-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDHQEOXPWBDFPL-QWRGUYRKSA-N 0.000 description 1
• WQOHKVRQDLNDIL-YJRXYDGGSA-N Tyr-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O WQOHKVRQDLNDIL-YJRXYDGGSA-N 0.000 description 1
• 102100029948 Tyrosine-protein phosphatase non-receptor type substrate 1 Human genes 0.000 description 1
• 208000025865 Ulcer Diseases 0.000 description 1
• 201000006704 Ulcerative Colitis Diseases 0.000 description 1
• 102100024689 Urokinase plasminogen activator surface receptor Human genes 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 206010046851 Uveitis Diseases 0.000 description 1
• 208000001445 Uveomeningoencephalitic Syndrome Diseases 0.000 description 1
• OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
• ZRSZTKTVPNSUNA-IHRRRGAJSA-N Val-Lys-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(O)=O ZRSZTKTVPNSUNA-IHRRRGAJSA-N 0.000 description 1
• UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 1
• 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 1
• 206010047115 Vasculitis Diseases 0.000 description 1
• 241001447269 Verminephrobacter eiseniae Species 0.000 description 1
• 206010047642 Vitiligo Diseases 0.000 description 1
• 208000025749 Vogt-Koyanagi-Harada disease Diseases 0.000 description 1
• 241000193453 [Clostridium] cellulolyticum Species 0.000 description 1
• 241001531188 [Eubacterium] rectale Species 0.000 description 1
• 238000002679 ablation Methods 0.000 description 1
• 238000005299 abrasion Methods 0.000 description 1
• 201000000621 achalasia Diseases 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 208000002552 acute disseminated encephalomyelitis Diseases 0.000 description 1
• 230000006978 adaptation Effects 0.000 description 1
• 238000007792 addition Methods 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 238000012382 advanced drug delivery Methods 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 208000004631 alopecia areata Diseases 0.000 description 1
• 206010002022 amyloidosis Diseases 0.000 description 1
• 210000003484 anatomy Anatomy 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
• PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
• 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 1
• 206010003230 arteritis Diseases 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 208000006424 autoimmune oophoritis Diseases 0.000 description 1
• 206010071578 autoimmune retinopathy Diseases 0.000 description 1
• 208000029407 autoimmune urticaria Diseases 0.000 description 1
• 230000002567 autonomic effect Effects 0.000 description 1
• 230000003376 axonal effect Effects 0.000 description 1
• 206010003882 axonal neuropathy Diseases 0.000 description 1
• 229940097012 bacillus thuringiensis Drugs 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 210000002960 bfu-e Anatomy 0.000 description 1
• 125000002619 bicyclic group Chemical group 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 229960000455 brentuximab vedotin Drugs 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• HXCHCVDVKSCDHU-LULTVBGHSA-N calicheamicin Chemical group C1[C@H](OC)[C@@H](NCC)CO[C@H]1O[C@H]1[C@H](O[C@@H]2C\3=C(NC(=O)OC)C(=O)C[C@](C/3=C/CSSSC)(O)C#C\C=C/C#C2)O[C@H](C)[C@@H](NO[C@@H]2O[C@H](C)[C@@H](SC(=O)C=3C(=C(OC)C(O[C@H]4[C@@H]([C@H](OC)[C@@H](O)[C@H](C)O4)O)=C(I)C=3C)OC)[C@@H](O)C2)[C@@H]1O HXCHCVDVKSCDHU-LULTVBGHSA-N 0.000 description 1
• 229950009667 camidanlumab tesirine Drugs 0.000 description 1
• 108020001778 catalytic domains Proteins 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 208000025434 cerebellar degeneration Diseases 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 210000003483 chromatin Anatomy 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
• 208000024376 chronic urticaria Diseases 0.000 description 1
• 229950009660 cofetuzumab pelidotin Drugs 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 230000004154 complement system Effects 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 230000001143 conditioned effect Effects 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 230000009260 cross reactivity Effects 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 201000007241 cutaneous T cell lymphoma Diseases 0.000 description 1
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• 230000001461 cytolytic effect Effects 0.000 description 1
• 210000005220 cytoplasmic tail Anatomy 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000018044 dehydration Effects 0.000 description 1
• 238000006297 dehydration reaction Methods 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 229950004079 denintuzumab mafodotin Drugs 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 229950008925 depatuxizumab mafodotin Drugs 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 229960004679 doxorubicin Drugs 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 201000002491 encephalomyelitis Diseases 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 230000002327 eosinophilic effect Effects 0.000 description 1
• 230000008029 eradication Effects 0.000 description 1
• 210000003013 erythroid precursor cell Anatomy 0.000 description 1
• 102000013165 exonuclease Human genes 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 208000002980 facial hemiatrophy Diseases 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 239000013020 final formulation Substances 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
• 210000004475 gamma-delta t lymphocyte Anatomy 0.000 description 1
• 229960003297 gemtuzumab ozogamicin Drugs 0.000 description 1
• 230000004077 genetic alteration Effects 0.000 description 1
• 231100000118 genetic alteration Toxicity 0.000 description 1
• 230000008826 genomic mutation Effects 0.000 description 1
• 208000018090 giant cell myocarditis Diseases 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
• 108010050848 glycylleucine Proteins 0.000 description 1
• 208000024908 graft versus host disease Diseases 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 201000009277 hairy cell leukemia Diseases 0.000 description 1
• 238000003306 harvesting Methods 0.000 description 1
• 230000003862 health status Effects 0.000 description 1
• 201000005787 hematologic cancer Diseases 0.000 description 1
• 230000002489 hematologic effect Effects 0.000 description 1
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
• 208000007475 hemolytic anemia Diseases 0.000 description 1
• 150000002402 hexoses Chemical class 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 108010085325 histidylproline Proteins 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 230000003463 hyperproliferative effect Effects 0.000 description 1
• 210000001822 immobilized cell Anatomy 0.000 description 1
• 230000006450 immune cell response Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 229940127121 immunoconjugate Drugs 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 229940051026 immunotoxin Drugs 0.000 description 1
• 230000002637 immunotoxin Effects 0.000 description 1
• 239000002596 immunotoxin Substances 0.000 description 1
• 231100000608 immunotoxin Toxicity 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 229950004101 inotuzumab ozogamicin Drugs 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 210000001821 langerhans cell Anatomy 0.000 description 1
• 108010090333 leucyl-lysyl-proline Proteins 0.000 description 1
• 201000011486 lichen planus Diseases 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 238000010872 live dead assay kit Methods 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 244000144972 livestock Species 0.000 description 1
• 229950009758 loncastuximab tesirine Drugs 0.000 description 1
• 238000011866 long-term treatment Methods 0.000 description 1
• 229950003526 lorvotuzumab mertansine Drugs 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 210000004324 lymphatic system Anatomy 0.000 description 1
• 201000011649 lymphoblastic lymphoma Diseases 0.000 description 1
• 230000000527 lymphocytic effect Effects 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 210000003593 megakaryocyte Anatomy 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 239000010445 mica Substances 0.000 description 1
• 229910052618 mica group Inorganic materials 0.000 description 1
• 239000011325 microbead Substances 0.000 description 1
• 229950003734 milatuzumab Drugs 0.000 description 1
• 230000033607 mismatch repair Effects 0.000 description 1
• 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 206010028417 myasthenia gravis Diseases 0.000 description 1
• 201000005962 mycosis fungoides Diseases 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 229950001422 naratuximab emtansine Drugs 0.000 description 1
• 201000003631 narcolepsy Diseases 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 201000008383 nephritis Diseases 0.000 description 1
• 208000004235 neutropenia Diseases 0.000 description 1
• 230000000683 nonmetastatic effect Effects 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 230000009438 off-target cleavage Effects 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 201000005737 orchitis Diseases 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 208000033808 peripheral neuropathy Diseases 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 229950010074 pinatuzumab vedotin Drugs 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• YIQPUIGJQJDJOS-UHFFFAOYSA-N plerixafor Chemical compound C=1C=C(CN2CCNCCCNCCNCCC2)C=CC=1CN1CCCNCCNCCCNCC1 YIQPUIGJQJDJOS-UHFFFAOYSA-N 0.000 description 1
• 229960002169 plerixafor Drugs 0.000 description 1
• 229950009416 polatuzumab vedotin Drugs 0.000 description 1
• 201000006292 polyarteritis nodosa Diseases 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 208000005987 polymyositis Diseases 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 210000004986 primary T-cell Anatomy 0.000 description 1
• 208000025638 primary cutaneous T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
• 201000006037 primary mediastinal B-cell lymphoma Diseases 0.000 description 1
• 201000000742 primary sclerosing cholangitis Diseases 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 229960003387 progesterone Drugs 0.000 description 1
• 239000000186 progesterone Substances 0.000 description 1
• 108010004914 prolylarginine Proteins 0.000 description 1
• 108010070643 prolylglutamic acid Proteins 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 208000005069 pulmonary fibrosis Diseases 0.000 description 1
• 208000009954 pyoderma gangrenosum Diseases 0.000 description 1
• 208000002574 reactive arthritis Diseases 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000008263 repair mechanism Effects 0.000 description 1
• 230000006335 response to radiation Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• RHFUOMFWUGWKKO-UHFFFAOYSA-N s2C Natural products S=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 RHFUOMFWUGWKKO-UHFFFAOYSA-N 0.000 description 1
• 229950001460 sacituzumab Drugs 0.000 description 1
• 229950000143 sacituzumab govitecan Drugs 0.000 description 1
• ULRUOUDIQPERIJ-PQURJYPBSA-N sacituzumab govitecan Chemical compound N([C@@H](CCCCN)C(=O)NC1=CC=C(C=C1)COC(=O)O[C@]1(CC)C(=O)OCC2=C1C=C1N(C2=O)CC2=C(C3=CC(O)=CC=C3N=C21)CC)C(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCN(N=N1)C=C1CNC(=O)C(CC1)CCC1CN1C(=O)CC(SC[C@H](N)C(O)=O)C1=O ULRUOUDIQPERIJ-PQURJYPBSA-N 0.000 description 1
• 201000000306 sarcoidosis Diseases 0.000 description 1
• 230000037390 scarring Effects 0.000 description 1
• 208000010157 sclerosing cholangitis Diseases 0.000 description 1
• 238000010845 search algorithm Methods 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 108010026333 seryl-proline Proteins 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 230000037432 silent mutation Effects 0.000 description 1
• 230000005783 single-strand break Effects 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 229950003763 sofituzumab vedotin Drugs 0.000 description 1
• 229960003787 sorafenib Drugs 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 229950009177 telisotuzumab vedotin Drugs 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 108010071097 threonyl-lysyl-proline Proteins 0.000 description 1
• 229940113082 thymine Drugs 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 238000003146 transient transfection Methods 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 108091007466 transmembrane glycoproteins Proteins 0.000 description 1
• 208000009174 transverse myelitis Diseases 0.000 description 1
• 229960000575 trastuzumab Drugs 0.000 description 1
• 229940049679 trastuzumab deruxtecan Drugs 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• HDZZVAMISRMYHH-KCGFPETGSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HDZZVAMISRMYHH-KCGFPETGSA-N 0.000 description 1
• 231100000397 ulcer Toxicity 0.000 description 1
• 230000004222 uncontrolled growth Effects 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• BNJNAEJASPUJTO-DUOHOMBCSA-N vadastuximab talirine Chemical compound COc1ccc(cc1)C2=CN3[C@@H](C2)C=Nc4cc(OCCCOc5cc6N=C[C@@H]7CC(=CN7C(=O)c6cc5OC)c8ccc(NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CCCCCN9C(=O)C[C@@H](SC[C@H](N)C(=O)O)C9=O)C(C)C)cc8)c(OC)cc4C3=O BNJNAEJASPUJTO-DUOHOMBCSA-N 0.000 description 1
• 229950001876 vandortuzumab vedotin Drugs 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1